跳至主要内容
临床试验/NCT00377806
NCT00377806已完成4 期

A One Week, Double-Blind, Adaptive, Randomized, Multicenter Study to Compare the Efficacy, Safety and Tolerability of Topical Diclofenac Gel Versus Placebo in Patients With Superficial Thrombophlebitis

Novartis2 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2003年1月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
Novartis
入组人数
200
试验地点
2
主要终点
The area under the curve (AUC) of the symptom score (pain, temperature and size of erythema along the superficial vein)

研究概览

简要总结

This study will assess the efficacy, safety and tolerability of topically administered diclofenac gel versus placebo with respect to the symptom score (pain, temperature and size of erythema along the superficial vein)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with indication of topical treatment for inflammatory, painful superficial thrombophlebitis of the upper limb
  • Spontaneous or iatrogenic superficial thrombophebitis of the upper limb

排除标准

  • Hypersensitivity to the study drug, to actylsalicyclic acid and other non-steroidal antirheumatic agents and to the ingredients of the gel
  • Paitents who had developed asthma, skin reactions or acute rhinitis to acetylsalicylic acid or other non-steroidal antirheumatic agents in the past
  • Therapy with varicose vein remedies, antithrombotic or antiphlogistic agents as well as corticosteroids for more than 7 days prior to study start
  • Acute deep vein thrombosis and thrombophlebitis extending into other deep veins
  • Other protocol-defined exclusion criteria may apply

结局指标

主要结局

The area under the curve (AUC) of the symptom score (pain, temperature and size of erythema along the superficial vein)

次要结局

  • Patient's global assessment of drug effect at each visit
  • Physician's global assessment of drug effect at each visit
  • AUC of assessment of pain (visual analog scale) between treatment day 1 and day 5
  • AUC of assessment of inflammatory area of the superficial thrombophlebitis between treatment day 1 and 5
  • AUC of assessment of temperature of inflammatory area around superficial thrombophlebitis between treatment day 1 and 5

研究者

发起方
Novartis
申办方类型
Industry

研究点 (2)

Loading locations...

相似试验